Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Targeted delivery of a-galactosylceramide to CD8a+ dendritic cells optimizes type I NKT cell-based antitumor responses.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.